Pulmonary delivery of DNA vaccine constructs using deacylated PEI elicits immune responses and protects against viral challenge infection
Open Access
- 1 September 2013
- journal article
- research article
- Published by Elsevier in Journal of Controlled Release
- Vol. 170 (3) , 452-459
Abstract
No abstract availableKeywords
Funding Information
- Bill & Melinda Gates Foundation
- Wellcome Trust
- Grand Challenges in Global Health Initiative (37872)
- CUT'HIVAC
- European Commission FP7 Award (241904)
This publication has 29 references indexed in Scilit:
- Airway CD8+ T cells induced by pulmonary DNA immunization mediate protective anti-viral immunityMucosal Immunology, 2013
- Polyethyleneimine is a potent mucosal adjuvant for viral glycoprotein antigensNature Biotechnology, 2012
- Glucopyranosyl Lipid Adjuvant (GLA), a Synthetic TLR4 Agonist, Promotes Potent Systemic and Mucosal Responses to Intranasal Immunization with HIVgp140PLOS ONE, 2012
- Transferrin conjugation confers mucosal molecular targeting to a model HIV-1 trimeric gp140 vaccine antigenJournal of Controlled Release, 2012
- Protective Efficacy of Serially Up-Ranked Subdominant CD8+ T Cell Epitopes against Virus ChallengesPLOS Pathogens, 2011
- Intranasal DNA Vaccination Induces Potent Mucosal and Systemic Immune Responses and Cross-protective Immunity Against Influenza VirusesMolecular Therapy, 2011
- Efficient Generation of Mucosal and Systemic Antigen-Specific CD8+T-Cell Responses following Pulmonary DNA ImmunizationJournal of Virology, 2010
- Cationic carriers of genetic material and cell death: A mitochondrial taleBiochimica et Biophysica Acta (BBA) - Bioenergetics, 2010
- Modulation of DNA Vaccine-Elicited CD8 + T-Lymphocyte Epitope Immunodominance HierarchiesJournal of Virology, 2006
- Airway gene transfer using cationic emulsion as a mucosal gene carrierThe Journal of Gene Medicine, 2005